
LINK . SPRINGER . COM {
}
Title:
Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines | Cellular and Molecular Life Sciences
Description:
In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies). We report here that injection of naked β-globin untranslated region (UTR)-stabilized mRNA coding for β-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application of recombinant granulocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the requirement of antiviral, antibacterial or antitumor immunity.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Mobile Technology & AI
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 8,280,528 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don’t know how the website earns money.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {🔍}
article, mrna, vaccination, vaccines, access, privacy, cookies, content, data, information, publish, research, search, injection, carralot, probst, pascolo, strategy, rna, log, journal, life, cmls, immunity, naked, hoerr, scheel, genetic, open, discover, author, tübingen, germany, cell, springer, optional, personal, parties, policy, find, track, cellular, molecular, sciences, polarization, induced, direct, sequencestabilized, cite, teufel,
Topics {✒️}
th1-type immune response globin utr-stabilized mrna month download article/chapter long-term uncontrolled expression anti-dna antibodies mrna vaccines stabilized mrna coding related subjects genetic vaccination privacy choices/manage cookies dna vaccination full article pdf vaccination strategy primes versatile vaccination strategy european economic area scope submit manuscript check access author correspondence instant access conditions privacy policy accepting optional cookies article cellular main content log vaccination strategy journal finder publish cell biology th2 article log life sci mrna vaccine article cite mrna injection article carralot privacy policy personal data β-galactosidase books a cell information optional cookies manage preferences essential cookies cookies skip subscription content similar content data protection data demonstrate pascolo institute institution subscribe journal publish
Schema {🗺️}
WebPage:
mainEntity:
headline:Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines
description:In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based
vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to
any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled
expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies).
We report here that injection of naked β-globin untranslated region (UTR)-stabilized mRNA coding for
β-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy
primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application
of recombinant granulocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the
administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the
requirement of antiviral, antibacterial or antitumor immunity.
datePublished:
dateModified:
pageStart:2418
pageEnd:2424
sameAs:https://doi.org/10.1007/s00018-004-4255-0
keywords:
Vaccination
Th1/Th2 cell
rodent
gene therapy
messenger RNA
GM-CSF
Cell Biology
Biomedicine
general
Life Sciences
Biochemistry
image:
isPartOf:
name:Cellular and Molecular Life Sciences CMLS
issn:
1420-9071
1420-682X
volumeNumber:61
type:
Periodical
PublicationVolume
publisher:
name:Birkhäuser-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:J.-P. Carralot
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:J. Probst
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:I. Hoerr
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:B. Scheel
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:R. Teufel
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:G. Jung
affiliation:
name:Institute of Organic Chemistry
address:
name:Institute of Organic Chemistry, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:H.-G. Rammensee
affiliation:
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:S. Pascolo
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines
description:In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based
vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to
any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled
expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies).
We report here that injection of naked β-globin untranslated region (UTR)-stabilized mRNA coding for
β-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy
primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application
of recombinant granulocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the
administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the
requirement of antiviral, antibacterial or antitumor immunity.
datePublished:
dateModified:
pageStart:2418
pageEnd:2424
sameAs:https://doi.org/10.1007/s00018-004-4255-0
keywords:
Vaccination
Th1/Th2 cell
rodent
gene therapy
messenger RNA
GM-CSF
Cell Biology
Biomedicine
general
Life Sciences
Biochemistry
image:
isPartOf:
name:Cellular and Molecular Life Sciences CMLS
issn:
1420-9071
1420-682X
volumeNumber:61
type:
Periodical
PublicationVolume
publisher:
name:Birkhäuser-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:J.-P. Carralot
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:J. Probst
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:I. Hoerr
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:B. Scheel
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:R. Teufel
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:G. Jung
affiliation:
name:Institute of Organic Chemistry
address:
name:Institute of Organic Chemistry, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:H.-G. Rammensee
affiliation:
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:S. Pascolo
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cellular and Molecular Life Sciences CMLS
issn:
1420-9071
1420-682X
volumeNumber:61
Organization:
name:Birkhäuser-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
name:Institute of Organic Chemistry
address:
name:Institute of Organic Chemistry, Tübingen, Germany
type:PostalAddress
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:J.-P. Carralot
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
name:J. Probst
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
name:I. Hoerr
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:B. Scheel
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
name:R. Teufel
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:G. Jung
affiliation:
name:Institute of Organic Chemistry
address:
name:Institute of Organic Chemistry, Tübingen, Germany
type:PostalAddress
type:Organization
name:H.-G. Rammensee
affiliation:
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
name:S. Pascolo
affiliation:
name:CureVac GmbH
address:
name:CureVac GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Department of Immunology
address:
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:CureVac GmbH, Tübingen, Germany
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
name:CureVac GmbH, Tübingen, Germany
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
name:CureVac GmbH, Tübingen, Germany
name:CureVac GmbH, Tübingen, Germany
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
name:CureVac GmbH, Tübingen, Germany
name:Institute of Organic Chemistry, Tübingen, Germany
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
name:CureVac GmbH, Tübingen, Germany
name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(39)
- Earnings of https://www.springernature.com/gp/authors
- What's the monthly income of https://link.springernature.com/home/?
- Find out how much https://order.springer.com/public/cart earns monthly
- https://www.editorialmanager.com/life/default2.aspx's financial summary
- Explore the financials of https://www.springernature.com/gp/librarians/licensing/agc/journals
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.-P.%20Carralot's financial summary
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.-P.%20Carralot%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Probst's financial summary
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Probst%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=I.%20Hoerr generate?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22I.%20Hoerr%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=B.%20Scheel pull in monthly?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22B.%20Scheel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20Teufel?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20Teufel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G.%20Jung?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G.%20Jung%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.-G.%20Rammensee each month?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.-G.%20Rammensee%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S.%20Pascolo pull in?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S.%20Pascolo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How much cash flow does https://s100.copyright.com/AppDispatchServlet?title=Polarization%20of%20immunity%20induced%20by%20direct%20injection%20of%20naked%20sequence-stabilized%20mRNA%20vaccines&author=J.-P.%20Carralot%20et%20al&contentID=10.1007%2Fs00018-004-4255-0©right=Birkh%C3%A4user-Verlag%20Basel&publication=1420-682X&publicationDate=2004-09&publisherName=SpringerNature&orderBeanReset=true have monthly?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00018-004-4255-0?format=refman&flavour=citation pull in?
- What is the monthly revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- Discover the revenue of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- https://www.springernature.com/gp/products's total income per month
- What's https://www.springernature.com/gp/librarians's gross income?
- https://www.springernature.com/gp/societies's total income per month
- What is the earnings of https://www.springernature.com/gp/partners?
- See how much https://www.springer.com/ makes per month
- How much money does https://www.nature.com/ make?
- Learn about the earnings of https://www.biomedcentral.com/
- https://www.palgrave.com/'s revenue stream
- What are the earnings of https://www.apress.com/?
- How much does https://www.springernature.com/gp/legal/ccpa rake in every month?
- Profit of https://www.springernature.com/gp/info/accessibility
- What's the total monthly financial gain of https://support.springernature.com/en/support/home?
- What's the financial gain of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How much does https://www.springernature.com/ earn?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref